世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

輸血デバイスの世界市場:製品別(アフェレシスシステム、輸液デバイス、血液ウォーマー、静脈アクセスデバイス、フィルター、その他)、血液成分別(全血、血漿、赤血球、その他)、エンドユーザー別(病院、外来手術センター、透析センター、血液銀行、その他)、地域別、競争、予測&機会(2026年)、等。


Global Blood Transfusion Devices Market By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), By Blood Component (Whole Blood, Plasma, RBC, Others), By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other), By Region, Competition, Forecast & Opportunities, 2026

輸血デバイスの世界市場は、予測期間中に約6%のCAGRで成長すると予想されています。輸血装置の世界市場は、世界中で実施されている外科手術の回数の急増によって駆動されています。また、技術的な発展は、予測期... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年7月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
116 英語

 

サマリー

輸血デバイスの世界市場は、予測期間中に約6%のCAGRで成長すると予想されています。輸血装置の世界市場は、世界中で実施されている外科手術の回数の急増によって駆動されています。また、技術的な発展は、予測期間中に市場の成長にプラスの影響を与えると予想されます。また、血液関連疾患の増加も、今後数年間の市場成長を後押しすると予想されます。
輸血デバイスの世界市場は、製品、タイプ、血液成分、エンドユーザー、企業、地域に基づいて区分されます。製品別では、アフェレシスシステム、インフュージョンデバイス、血液ウォーマー、静脈アクセスデバイス、フィルター、その他に分類することができます。このうち、アフェレシスシステムセグメントは、2020年まで最大の市場シェアで市場を支配しており、予測期間中も市場の主導的地位を維持すると予想されます。これは、白血病の白血球数の増加によって引き起こされる白血球増加症の治療に広く使用されていることに起因しています。さらに、アフェレシスシステムは、抗体による臓器拒絶反応を最小限に抑えるため、重症関節リウマチの治療、全身性狼瘡、グッドパスチャー症候群、多発性筋炎や皮膚真菌症、妊娠中の子癇前症や子癇にも用いられており、今後数年間でこの分野の成長を押し上げると予想されます。
世界の輸血デバイス市場で事業を展開している主な企業は、Fresenius Kabi AG、Grifols S.A.、テルモ株式会社、B. Braun Melsungen AG、Becton, Dickinson, Company、 Immucor Inc.、 Haemonetics Corporation、株式会社カネカ、Macopharma SA、Tenko International Group Corp などです。各社は市場での競争力を維持するために、先進的な技術の開発や新製品の投入を行っています。その他の競争戦略には、M&A、提携、合意、新規開発などがあります。
本レポートで考慮した年数
歴史的年数:2016年~2019年
基準年:2020年
予測年:2021年
予測年:2022年〜2026年
本調査の目的
- 2016年から2020年までの輸血用デバイスの世界市場規模を分析・推計する。
- 2021年から2026年までの輸血デバイスの世界市場規模および2026年までの成長率を予測・推計する。
- 輸血デバイスの世界市場を製品、血液成分、エンドユーザー、企業、地域分布に基づき分類・予測する。
- 世界の輸血デバイス市場における支配的な地域やセグメントを特定する。
- 世界の輸血デバイス市場のドライバーと課題を特定する。
- 世界の輸血装置市場における拡張、新製品発表、M&Aなどの競争展開を検討する。
- 世界の輸血デバイス市場の価格分析を行うため。
- 世界の輸血機器市場で事業を展開する主要企業のプロファイルを特定し、分析する。
- 世界の輸血装置市場で市場参入企業が採用する主要な持続可能な戦略を特定する。
TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。最初に、TechSci Researchは世界中のメーカーのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査の調査を実施した。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかったメーカーを含めることができました。TechSci Researchは、全世界のメーカーと主要プレイヤーの存在を分析しました。
TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来の予測を行うボトムアップアプローチを用いて、世界の輸血装置市場の市場規模を算出しました。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプやアプリケーションの履歴データの分析を通じて外部で検証しました。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- 輸血装置メーカー、サプライヤー、その他の関係者
- 規制当局や政策立案者などの政府機関
- 輸血デバイスに関連する組織、フォーラム、アライアンス
- 市場調査会社およびコンサルティング会社
本調査は、メーカー、サプライヤー、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに、投資戦略を立て、市場機会を活用する上で有用である。
レポートの範囲
本レポートでは、輸血デバイスの世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。
- 輸血デバイスの世界市場、製品別
o アフェレシスシステム
o 輸血デバイス
o 血液ウォーマー
o 静脈アクセスデバイス
o フィルタ
o その他
- 輸血デバイスの世界市場:血液成分別
o 全血
o 血漿
o 赤血球
o その他
- 輸血デバイスの世界市場:エンドユーザー別
o 病院
o 外来手術センター
o 透析センター
o 血液銀行
o その他
- 輸血デバイスの世界市場:地域別
o 北米
米国
カナダ
メキシコ
o ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
o アジア太平洋地域
中国
日本
インド
韓国
オーストラリア
o 中東・アフリカ
南アフリカ共和国
サウジアラビア
UAE
クウェート
o 南米
ブラジル
アルゼンチン
コロンビア
競合他社の状況
企業プロファイル。輸血装置の世界市場における主要企業の詳細な分析。
利用可能なカスタマイズ。
TechSci Researchでは、与えられた市場データをもとに、企業特有のニーズに応じたカスタマイズを提供しています。本レポートでは、以下のカスタマイズが可能です。
企業情報
- 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社)。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Blood Transfusion Devices Market
4. Executive Summary
5. Voice of Customer
6. Global Blood Transfusion Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
6.2.2. By Blood Component (Whole Blood, Plasma, RBC, Others)
6.2.3. By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other)
6.2.4. By Company (2020)
6.2.5. By Region
6.3. Product Market Map
7. Asia-Pacific Blood Transfusion Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Blood Component
7.2.3. By End User
7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Blood Transfusion Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Blood Component
7.3.1.2.3. By End User
7.3.2. India Blood Transfusion Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Blood Component
7.3.2.2.3. By End User
7.3.3. Australia Blood Transfusion Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Blood Component
7.3.3.2.3. By End User
7.3.4. Japan Blood Transfusion Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Blood Component
7.3.4.2.3. By End User
7.3.5. South Korea Blood Transfusion Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Blood Component
7.3.5.2.3. By End User
8. Europe Blood Transfusion Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Blood Component
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Blood Transfusion Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Blood Component
8.3.1.2.3. By End User
8.3.2. Germany Blood Transfusion Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Blood Component
8.3.2.2.3. By End User
8.3.3. United Kingdom Blood Transfusion Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Blood Component
8.3.3.2.3. By End User
8.3.4. Italy Blood Transfusion Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Blood Component
8.3.4.2.3. By End User
8.3.5. Spain Blood Transfusion Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Blood Component
8.3.5.2.3. By End User
9. North America Blood Transfusion Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Blood Component
9.2.3. By End User
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Blood Transfusion Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Blood Component
9.3.1.2.3. By End User
9.3.2. Mexico Blood Transfusion Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Blood Component
9.3.2.2.3. By End User
9.3.3. Canada Blood Transfusion Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Blood Component
9.3.3.2.3. By End User
10. South America Blood Transfusion Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Blood Component
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood Transfusion Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Blood Component
10.3.1.2.3. By End User
10.3.2. Argentina Blood Transfusion Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Blood Component
10.3.2.2.3. By End User
10.3.3. Colombia Blood Transfusion Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Blood Component
10.3.3.2.3. By End User
11. Middle East and Africa Blood Transfusion Devices Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Blood Component
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Blood Transfusion Devices Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Blood Component
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Blood Component
11.3.2.2.3. By End User
11.3.3. UAE Blood Transfusion Devices Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Blood Component
11.3.3.2.3. By End User
11.3.4. Kuwait Blood Transfusion Devices Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Blood Component
11.3.4.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Fresenius Kabi AG
14.2.2. Grifols S.A.
14.2.3. Terumo Corporation
14.2.4. B. Braun Melsungen AG
14.2.5. Becton, Dickinson, and Company
14.2.6. Immucor Inc.
14.2.7. Haemonetics Corporation
14.2.8. Kaneka Corporation
14.2.9. Macopharma SA
14.2.10. Tenko International Group Corp
15. Strategic Recommendations
16. About Us & Disclaimer

 

ページTOPに戻る


 

Summary

Global blood transfusion devices market is expected to grow at a CAGR of around 6% during the forecast period. The global blood transfusion devices market is driven by upsurge in count of surgical procedures being carried out across the globe. Moreover, developments in terms of technology is expected to positively impact the growth of the market during the forecast period. Also, rise in number of blood related disorders is further expected to bolster the growth of market over the next few years.
The global blood transfusion devices market is segmented based on product, type, blood component, end user, company, and region. Based on product, the market can be categorized into apheresis systems, infusion devices, blood warmers, venous access devices, filters, and others. Out of these, the apheresis systems segment dominated the market in terms of largest market share until 2020 and is expected to maintain leading position in the market during the forecast period as well. This can be ascribed to its wide use for the treatment of leukostasis, which is caused by increased white blood count in leukaemia. In addition to this, apheresis system is also used for treating severe rheumatoid arthritis, in order to minimize the risk associated with antibody-mediated rejection of organ during, systemic lupus, goodpasture syndrome, polymyositis or dermatomycosis, and preeclampsia and eclampsia during pregnancy, which is anticipated to boost the growth of the segment over the coming years.
Major players operating in the global blood transfusion devices market include Fresenius Kabi AG, Grifols S.A., Terumo Corporation, B. Braun Melsungen AG, Becton, Dickinson, Company, Immucor Inc., Haemonetics Corporation, Kaneka Corporation, Macopharma SA, Tenko International Group Corp and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments.
Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022-2026
Objective of the Study:
• To analyze and estimate the market size of global blood transfusion devices market from 2016 to 2020.
• To estimate and forecast the market size of global blood transfusion devices market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast global blood transfusion devices market based on product, blood component, end user, company and regional distribution.
• To identify dominant region or segment in the global blood transfusion devices market.
• To identify drivers and challenges for global blood transfusion devices market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global blood transfusion devices market.
• To conduct pricing analysis for global blood transfusion devices market.
• To identify and analyze the profile of leading players operating in global blood transfusion devices market.
• To identify key sustainable strategies adopted by market players in global blood transfusion devices market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers and presence of all major players across the globe.
TechSci Research calculated the market size of global blood transfusion devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Blood transfusion devices manufacturers, suppliers and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to blood transfusion devices
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global blood transfusion devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Global Blood Transfusion Devices Market, By Product:
o Apheresis Systems
o Infusion Devices
o Blood Warmers
o Venous Access Devices
o Filters
o Others
• Global Blood Transfusion Devices Market, By Blood Component:
o Whole Blood
o Plasma
o RBC
o Others
• Global Blood Transfusion Devices Market, By End User:
o Hospital
o Ambulatory Surgical Centers
o Dialysis Centers
o Blood Bank
o Other
• Global Blood Transfusion Devices Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Kuwait
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global blood transfusion devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Blood Transfusion Devices Market
4. Executive Summary
5. Voice of Customer
6. Global Blood Transfusion Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
6.2.2. By Blood Component (Whole Blood, Plasma, RBC, Others)
6.2.3. By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other)
6.2.4. By Company (2020)
6.2.5. By Region
6.3. Product Market Map
7. Asia-Pacific Blood Transfusion Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Blood Component
7.2.3. By End User
7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Blood Transfusion Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Blood Component
7.3.1.2.3. By End User
7.3.2. India Blood Transfusion Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Blood Component
7.3.2.2.3. By End User
7.3.3. Australia Blood Transfusion Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Blood Component
7.3.3.2.3. By End User
7.3.4. Japan Blood Transfusion Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Blood Component
7.3.4.2.3. By End User
7.3.5. South Korea Blood Transfusion Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Blood Component
7.3.5.2.3. By End User
8. Europe Blood Transfusion Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Blood Component
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Blood Transfusion Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Blood Component
8.3.1.2.3. By End User
8.3.2. Germany Blood Transfusion Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Blood Component
8.3.2.2.3. By End User
8.3.3. United Kingdom Blood Transfusion Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Blood Component
8.3.3.2.3. By End User
8.3.4. Italy Blood Transfusion Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Blood Component
8.3.4.2.3. By End User
8.3.5. Spain Blood Transfusion Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Blood Component
8.3.5.2.3. By End User
9. North America Blood Transfusion Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Blood Component
9.2.3. By End User
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Blood Transfusion Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Blood Component
9.3.1.2.3. By End User
9.3.2. Mexico Blood Transfusion Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Blood Component
9.3.2.2.3. By End User
9.3.3. Canada Blood Transfusion Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Blood Component
9.3.3.2.3. By End User
10. South America Blood Transfusion Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Blood Component
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood Transfusion Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Blood Component
10.3.1.2.3. By End User
10.3.2. Argentina Blood Transfusion Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Blood Component
10.3.2.2.3. By End User
10.3.3. Colombia Blood Transfusion Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Blood Component
10.3.3.2.3. By End User
11. Middle East and Africa Blood Transfusion Devices Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Blood Component
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Blood Transfusion Devices Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Blood Component
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Blood Component
11.3.2.2.3. By End User
11.3.3. UAE Blood Transfusion Devices Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Blood Component
11.3.3.2.3. By End User
11.3.4. Kuwait Blood Transfusion Devices Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Blood Component
11.3.4.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Fresenius Kabi AG
14.2.2. Grifols S.A.
14.2.3. Terumo Corporation
14.2.4. B. Braun Melsungen AG
14.2.5. Becton, Dickinson, and Company
14.2.6. Immucor Inc.
14.2.7. Haemonetics Corporation
14.2.8. Kaneka Corporation
14.2.9. Macopharma SA
14.2.10. Tenko International Group Corp
15. Strategic Recommendations
16. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(二次医療)の最新刊レポート

TechSci Research社の二次医療分野での最新刊レポート

本レポートと同じKEY WORD(surgical)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る